J
Jiean Xu
H指数:17
被引数:1,288
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
PFKFB3 activates CAD to enhance de novo pyrimidine synthesis for cell growth
PFKFB3激活CAD以增强从头嘧啶合成促进细胞生长
Cell Reports
IF6.9
Erchen Decoction and its active flavonoids hesperidin and quercetin alleviate high-fat diet-induced neuroinflammation by targeting HK2-mediated microglial glycolysis
二陈汤及其活性黄酮类物质橙皮苷和槲皮素通过靶向HK2介导的小胶质细胞糖酵解,缓解高脂饮食诱导的神经炎症。
Targeting adenosine 2 A receptor signaling suppresses vascular calcification by restraining smooth muscle osteogenic differentiation
靶向腺苷2A受体信号传导通过抑制平滑肌细胞的成骨分化来抑制血管钙化
Pharmacological Research
IF10.5
Endothelial adenosine receptor 2A loss alleviates diabetic vascular calcification by blocking CREB1-SNAI1-driven EndMT
内皮腺苷受体2A缺失通过阻断CREB1-SNAI1驱动的EndMT来缓解糖尿病血管钙化
Pharmacological Research
IF10.5
PFKFB3 activates CAD to enhance de novo pyrimidine synthesis for cell growth
PFKFB3激活CAD以增强从头嘧啶合成以促进细胞生长
Cell Reports
IF6.9
Long-Acting and Stapled GLP-1R/GIPR/GCGR Triple Agonist for the Treatment of Obesity and Atherosclerosis
长效和 Stapled GLP-1R/GIPR/GCGR 三重激动剂用于治疗肥胖和动脉粥样硬化
Blockade of endothelial adenosine receptor 2 A suppresses atherosclerosis in vivo through inhibiting CREB-ALK5-mediated endothelial to mesenchymal transition
阻断内皮细胞腺苷受体2 a通过抑制CREB-ALK5-mediated内皮细胞向间充质细胞转化抑制体内动脉粥样硬化
PHARMACOLOGICAL RESEARCH
IF10.5
ATIC-Associated De Novo Purine Synthesis Is Critically Involved in Proliferative Arterial Disease
与ATIC相关的从头嘌呤合成在增生性动脉疾病中至关重要
CIRCULATION
IF38.6
Suppression of myeloid PFKFB3-driven glycolysis protects mice from choroidal neovascularization
抑制髓样PFKFB3-driven糖酵解保护小鼠脉络膜新生血管

